Study | Patient | Normal for Age |
---|---|---|
Phenotype Analysis | ||
   Lymphocytes/mm3 | 1818 | 6000 ± 1500 |
   CD2, % | 70 | 73 ± 8 |
   CD3, % | 62 | 66 ± 13 |
   CD4, % | 42 | 43 ± 12 |
   CD8, %, | 19 | 25 ± 9 |
   CD45RA+CD3, % | 79 | 64 – 93 |
   CD45RO+CD3, % | 11 |  |
   CD25+CD4, % | 14 | <3 |
   CD20, % | 14 | 8 ± 3 |
   smIgM, % | 11 | 4 – 16 |
   smIgM, % | 10 | 3 – 15 |
   CD56, % | 10 | 13 ± 7 |
Lymphoproliferative Responses | ||
   PHA, cpm | 164,082 | 100,530 – 657,376 |
%NR | 65 | >50 |
   Con A, cpm | 10 | 53,173 – 502,758 |
%NR | 0 | >50 |
   PWM, cpm | 121,168 | 40,305 – 337,597 |
%NR | 96 | >50 |
   MLC, cpm | 118,219 | 43,801 – 328,175 |
SI | 23.2 | >3.0 |
Immunoglobulins | ||
IgG, mg/dl | 113 | 399–1068 |
IgA, mg/dl | 11 | 15–95 |
IgM, mg/dl | 97 | 49–202 |
IgE, IU/ml | <2 | 3–29 |
anti-HiB, μg/ml | <0.5 | >1.0 |
anti-Diphtheria toxoid, IU/ml | 1.61 | >0.05 |
anti-Tetanus toxoid, IU/ml | 0.2 | >0.5 |
anti-Streptococcus, μg/ml | ||
Serotype 4 | 4.6 | >2.0 |
Serotype 6 | 2.2 | >2.0 |
Serotype 9 | 0.3 | >2.0 |
Serotype 14 | 1.0 | >2.0 |
Serotype 18 | 12.2 | >2.0 |
Serotype 19 | 0.9 | >2.0 |
Serotype 23 | 0.3 | >2.0 |
CH50, U/ml | 64 | 31 – 64 |